---
title: "Adaptimmune Therap (ADAP.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/ADAP.US/norm.md"
symbol: "ADAP.US"
name: "Adaptimmune Therap"
parent: "https://longbridge.com/zh-HK/quote/ADAP.US.md"
datetime: "2026-03-13T18:40:43.800Z"
locales:
  - [en](https://longbridge.com/en/quote/ADAP.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ADAP.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ADAP.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/ADAP.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/ADAP.US/norm.md)


# Adaptimmune Therap (ADAP.US) — 財務報表

## 損益表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.1200 | -0.1851 | -0.3090 | -0.0689 | 0.2400 |
| ROE | 223.94% | 1488.16% | -646.49% | -79.96% | 460.98% |
| Revenue | 13.68M | 7.29M | 3.22M | 40.90M | 128.23M |
| Net income | -30.34M | -47.58M | -74.22M | -17.62M | 69.52M |

## 資產負債表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 130.63M | 158.07M | 245.96M | 317.44M | 321.70M |
| Leverage | -1.84 | -4.22 | 20.76 | 3.97 | 3.34 |
| BVPS | -0.2677 | -0.1452 | 0.0463 | 0.3127 | 0.3765 |
| Turnover | 0.2878 | 0.8635 | 0.6736 | 0.5701 | 0.4256 |

## 現金流量表 (USD)

| 指標 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -34.78M | -66.59M | -34.20M | -54.45M | 47.40M |
| Investing CF | 18.49M | 41.15M | 8.17M | -66.02M | -743000.00 |
| Financing CF | 1.65M | -25.32M | 1000.00 | 25.00M | 24.51M |
| Free CF | -23.24M | -45.86M | -13.73M | -40.38M | 67.87M |